Interchange Capital Partners’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-4,732
Closed -$262K 477
2026
Q1
$262K Buy
+4,732
New +$221K 0.08% 220
2025
Q2
Sell
-5,439
Closed -$302K 314
2025
Q1
$302K Sell
5,439
-109
-2% -$5.9K 0.08% 201
2024
Q4
$268K Sell
5,548
-539
-9% -$27.4K 0.1% 200
2024
Q3
$351K Sell
6,087
-45
-0.7% -$2.43K 0.12% 179
2024
Q2
$297K Buy
+6,132
New +$296K 0.11% 192
2023
Q2
Sell
-4,558
Closed -$249K 214
2023
Q1
$249K Buy
+4,558
New +$222K 0.14% 173
2021
Q1
Sell
-4,724
Closed -$229K 955
2020
Q4
$229K Buy
+4,724
New +$233K 0.12% 189

Other funds holding SNY

Interchange Capital Partners's SNY Position: Q2 2026 in Review

Interchange Capital Partners sold out of Sanofi (SNY) in Q2 2026, closing a stake of 4,732 shares — an estimated $262K sold.

Interchange Capital Partners first reported a position in SNY in Q4 2020 and held it in 7 quarters. The position peaked at $351K in Q3 2024. 716 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Interchange Capital Partners reported no remaining Sanofi position as of Q2 2026 after selling out during the quarter.
  • Interchange Capital Partners sold 4,732 Sanofi shares in Q2 2026, an estimated $262K.
  • Interchange Capital Partners first reported a position in Sanofi in Q4 2020 and held it in 7 quarters.
  • Interchange Capital Partners's Sanofi position peaked at $351K in Q3 2024.
  • 716 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Interchange Capital Partners's 13F filing for Q2 2026, filed 20 Jul 2026.